Cart
sales@molnova.com
Katacine
CAS No. 135151-34-7
Katacine( —— )
Catalog No. M17252 CAS No. 135151-34-7
Katacine inhibits of oxygen consumption and suppresses the speed of electrons transfer from oxidation substrates via respiratory chain of mitochondria to molecular oxygen.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 122 | In Stock |
|
| 5MG | 236 | In Stock |
|
| 10MG | 433 | In Stock |
|
| 25MG | 708 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameKatacine
-
NoteResearch use only, not for human use.
-
Brief DescriptionKatacine inhibits of oxygen consumption and suppresses the speed of electrons transfer from oxidation substrates via respiratory chain of mitochondria to molecular oxygen.
-
DescriptionKatacine inhibits of oxygen consumption and suppresses the speed of electrons transfer from oxidation substrates via respiratory chain of mitochondria to molecular oxygen.Katacine is a mixture of polymers of A-type proanthocyanidins at various stages of polymerisation , from Polygonum coriarium of the Polygonaceae family. Katacine is an antihypoxic.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
Targetc-Kit
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number135151-34-7
-
Formula Weight——
-
Molecular Formula(C15H13O7)-[C15H12O7]n-(C15H13O7)
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
KBP-7018 hydrochlori...
A novel potent, multikinase inhibitor with IC50 of 10, 7.6 and 25 nM for c-Kit, RET and PDGFRβ, respectively.
-
Masitinib
A potent tyrosine kinase inhibitor targeting c-Kit and PDGFR with IC50 of 0.15 and 0.05 uM in cell based assays.
-
Sitravatinib
A novel, broad spectrum small molecule inhibitor that blocks a wide array of RTKs known to be amplified/overexpressed in sarcomas, including c-Kit, PDGFRβ, PDGFRα, c-Met, and Axl (IC50=1.5-30 nM).
